2023 annual financial data
Oncolytics Biotech 2023 Financial results
Direct answer
Revenue was 0 CAD.
Operating income was -25,471,883 CAD and net income was -20,919,644 CAD.
Operating cash flow was -21,444,293 CAD.
Get free Oncolytics Biotech email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 CAD
- Operating income
- -25,471,883 CAD
- Net income
- -20,919,644 CAD
- Operating cash flow
- -21,444,293 CAD
Explore related company data
View all 2023 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all Oncolytics Biotech financial years